Formulation Development White Papers & Articles

  1. Ready To Demystify Organoids? 7/1/2025

    Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.

  2. Efficiently Select Your Antibody Or Antibody Variant Purification Strategy 7/1/2025

    Explore the evolution of antibody therapeutics from monoclonal antibodies to next-gen formats and discover innovative strategies for purifying these complex molecules in today’s landscape.

  3. Efficiently Select And Optimize Antibody Candidates 7/1/2025

    Discover how innovative systems streamline antibody development to enhance target-binding analysis, optimize therapeutic selection, and accelerate clinical success with precision tools.

  4. Streamline Your Pathway To IND With A Rapid Tox Approach 6/26/2025

    With tox material in hand as soon as possible, antibody-derived drug developers can conduct their tox studies earlier, facilitating a timely IND submission and speeding up pathways to patients.

  5. Experimental Pain Models — SNL Model Of Neuropathic Pain 6/20/2025

    Explore how a validated Spinal Nerve Ligation (SNL) model enables effective preclinical evaluation of novel analgesics for neuropathic pain.

  6. Quicker Development Using Cell Line Integration, End-To-End Support 6/19/2025

    Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.

  7. Experimental CCI — Induced Neuropathic Pain Model 6/18/2025

    Advance neuropathic pain research and therapeutic development with the Chronic Constriction Injury (CCI)-induced neuropathic pain model to uncover mechanisms and evaluate promising candidates.

  8. Manufacturing CAR T Cell Therapies: Challenges, Insights And Solutions 6/16/2025

    Manufacturing patient-specific cell therapies is a complex, multi-step process. Addressing key hurdles in production time, scalability, and cost is crucial to making these vital treatments more accessible.

  9. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge Rodent Models 6/10/2025

    Here, we present multiple case studies utilizing clinically relevant mouse and rat models to evaluate key characteristics of potential RSV therapeutics.

  10. Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models 6/10/2025

    Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.